Stockreport

Pieris Pharmaceuticals Second Quarter 2024 Earnings: US$2.76 loss per share (vs US$3.63 profit in 2Q 2023) [Yahoo! Finance]

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com
PDF US$2.76 loss per share (down from US$3.63 profit in 2Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Pieris Pharmaceuticals [Read more]